The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global over the counter (OTC) drugs market was valued at US$ 148 Billion in 2021.
We expect the global over the counter (OTC) drugs market to exhibit a CAGR of 6.44% during 2022-
The increasing utilization of OTC drugs to treat minor ailments, along with the growing demand for
nutritional supplements, owing to the emerging trend of self-care, is currently driving the global over
the counter (OTC) drugs market.
The sudden outbreak of the COVID-19 pandemic has led to the rising inclination towards OTC drugs,
including antibiotics, multi-vitamin tablets, cough syrups, etc., for treating the mild symptoms of
Based on the product type, the global over the counter (OTC) drugs market has been divided into
cough, cold and flu products, analgesics, dermatology products, gastrointestinal products, Vitamins,
Minerals and Supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids,
and others. Among these, cough, cold and flu products currently exhibit a clear dominance in the
Based on the route of administration, the global over the counter (OTC) drugs market can be
categorized into oral, parenteral, topical, and others. Currently, oral route of administration holds
the majority of the total market share.
Based on the dosage form, the global over the counter (OTC) drugs market has been segmented into
tablets and capsules, liquids, ointments, and others. Among these, tablets and capsules currently
represent the largest market share.
Based on the distribution channel, the global over the counter (OTC) drugs market can be bifurcated
into hospital pharmacies, retail pharmacies, online pharmacies, and others. Currently, retail
pharmacies account for the majority of the global market share.
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global over the counter (OTC) drugs market include Alkem
Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd.,
GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal
Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., and
Teva Pharmaceutical Industries Ltd.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at